Automatic Implantable Cardioverter Defibrillator in Critical Care and EmergencyRoom Settings

摘要

An in-depth exploration into the automatic implantable cardioverter defibrillator(AICD) is the purpose of this paper. Developed to treat recurrent fatal ventricular arrhythmias by delivering a countershock, the AICD provides increased protection for patients who have survived sudden cardiac death. Because of the increased numbers of people surviving sudden cardiac death, ineffective antiarrhythmic drug therapy and an unpredictable response to surgical interventions, AICD technology and subsequent implants are increasing at alarming rates. Criteria established by the Food and Drug Administration, along with physical and psychological factors, govern whether or not these implantations occur. AICD implantation, via one of four surgical approaches, involves intraoperative testing and continual postoperative surveillance of the patient's response and device function.